Bardet-Biedl syndrome

Revision as of 18:52, 19 October 2008 by Swilliams (Talk | contribs)

Jump to: navigation, search
Bardet-Biedl syndrome
ICD-10 Q87.8
ICD-9 759.89
OMIM 209900
DiseasesDB 7286
MeSH D020788

WikiDoc Resources for

Bardet-Biedl syndrome

Articles

Most recent articles on Bardet-Biedl syndrome

Most cited articles on Bardet-Biedl syndrome

Review articles on Bardet-Biedl syndrome

Articles on Bardet-Biedl syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bardet-Biedl syndrome

Images of Bardet-Biedl syndrome

Photos of Bardet-Biedl syndrome

Podcasts & MP3s on Bardet-Biedl syndrome

Videos on Bardet-Biedl syndrome

Evidence Based Medicine

Cochrane Collaboration on Bardet-Biedl syndrome

Bandolier on Bardet-Biedl syndrome

TRIP on Bardet-Biedl syndrome

Clinical Trials

Ongoing Trials on Bardet-Biedl syndrome at Clinical Trials.gov

Trial results on Bardet-Biedl syndrome

Clinical Trials on Bardet-Biedl syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bardet-Biedl syndrome

NICE Guidance on Bardet-Biedl syndrome

NHS PRODIGY Guidance

FDA on Bardet-Biedl syndrome

CDC on Bardet-Biedl syndrome

Books

Books on Bardet-Biedl syndrome

News

Bardet-Biedl syndrome in the news

Be alerted to news on Bardet-Biedl syndrome

News trends on Bardet-Biedl syndrome

Commentary

Blogs on Bardet-Biedl syndrome

Definitions

Definitions of Bardet-Biedl syndrome

Patient Resources / Community

Patient resources on Bardet-Biedl syndrome

Discussion groups on Bardet-Biedl syndrome

Patient Handouts on Bardet-Biedl syndrome

Directions to Hospitals Treating Bardet-Biedl syndrome

Risk calculators and risk factors for Bardet-Biedl syndrome

Healthcare Provider Resources

Symptoms of Bardet-Biedl syndrome

Causes & Risk Factors for Bardet-Biedl syndrome

Diagnostic studies for Bardet-Biedl syndrome

Treatment of Bardet-Biedl syndrome

Continuing Medical Education (CME)

CME Programs on Bardet-Biedl syndrome

International

Bardet-Biedl syndrome en Espanol

Bardet-Biedl syndrome en Francais

Business

Bardet-Biedl syndrome in the Marketplace

Patents on Bardet-Biedl syndrome

Experimental / Informatics

List of terms related to Bardet-Biedl syndrome

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Laurence-Moon-Biedl syndrome and Laurence-Moon-Biedl-Bardet redirect here. See below for an explanation.

The Bardet-Biedl syndrome is a genetic disorder characterized mainly by obesity, pigmentary retinopathy, polydactyly, mental retardation, hypogonadism, and renal failure in some cases.[1]

Eponym and classification

The syndrome is named after Georges Bardet and Arthur Biedl.[2]

Two forms have been identified:

  • Bardet-Biedl syndrome 1 (BBS1) has no linkage to chromosome 16
  • Bardet-Biedl syndrome 2 (BBS2) is mapped to markers on chromosome 16.

The first known case was reported by Laurence and Moon in 1866 at the Ophthalmic Hospital in South London. Laurence-Moon-Biedl-Bardet syndrome are no longer considered as valid terms in that patients of Laurence and Moon had paraplegia but no polydactyly and obesity which are the key elements of the Bardet-Biedl the syndrome. Laurence-Moon syndrome is usually considered a separate entity. However, some recent research suggests that the two conditions may not be distinct.[3]

Major features

Cause

The detail biochemical mechanism that leads to BBS is still unclear. Recently, eight genes (BBS1 to BBS8) that are responsible for the disease when mutated have been cloned, and most of the gene products encoded by these BBS genes are located in the basal body and cilia of the cell. It has been postulated that these BBS gene products might involve in the cell signaling pathway in the cilia, and these signaling systems play an essential role in the normal development so that a malfunction in these systems causes the diverse pathological effects of the Syndrome.

In addition to so-called "signaling' along the cilia, it appears that Intraflagellar transport (IFT) of proteins along the cilia are essential for the formation and maintenance of healthy cells. In particular, abnormalities in retinal cilia are hypothesized to be related to the retinal dystrophy which is common in BBS patients.

June 2006 Conference

  • The LMBBS Association Family Meeting for non-medical-professionals was held in Houston, Texas, June 16-17, 2006.
The conference was sponsored by a steering committee of BBS folk and parents/grandparents of children with BBS. It was directed to a lay audience.
A primary purpose of the conference was to present the latest medical research results in an accessible fashion. This included one morning of presentations by leading BBS genetic researchers Dr. Richard Lewis (Baylor Medical Center, Houston) and Dr. Nicholas Katsanis (Johns Hopkins University, Baltimore, Maryland). Several additional doctors presented accessible information on growth and weight management; kidney issues; obesity & Syndrome X; pediatric bariatric surgery; and speech pathology & therapy.
Location: Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.
For additional information about the meeting, click here.

References

  1. Beales P, Elcioglu N, Woolf A, Parker D, Flinter F (1999). "New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey". J. Med. Genet. 36 (6): 437-46. PMID 10874630.
  2. synd/3745 at Who Named It
  3. Moore S, Green J, Fan Y et al (2005). "Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study". Am. J. Med. Genet. A 132 (4): 352-60. PMID 15637713.

External links

Cost Effectiveness of Bardet-Biedl syndrome

| group5 = Clinical Trials Involving Bardet-Biedl syndrome | list5 = Ongoing Trials on Bardet-Biedl syndrome at Clinical Trials.govTrial results on Bardet-Biedl syndromeClinical Trials on Bardet-Biedl syndrome at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Bardet-Biedl syndrome | list6 = US National Guidelines Clearinghouse on Bardet-Biedl syndromeNICE Guidance on Bardet-Biedl syndromeNHS PRODIGY GuidanceFDA on Bardet-Biedl syndromeCDC on Bardet-Biedl syndrome


| group7 = Textbook Information on Bardet-Biedl syndrome | list7 = Books and Textbook Information on Bardet-Biedl syndrome


| group8 = Pharmacology Resources on Bardet-Biedl syndrome | list8 = AND (Dose)}} Dosing of Bardet-Biedl syndromeAND (drug interactions)}} Drug interactions with Bardet-Biedl syndromeAND (side effects)}} Side effects of Bardet-Biedl syndromeAND (Allergy)}} Allergic reactions to Bardet-Biedl syndromeAND (overdose)}} Overdose information on Bardet-Biedl syndromeAND (carcinogenicity)}} Carcinogenicity information on Bardet-Biedl syndromeAND (pregnancy)}} Bardet-Biedl syndrome in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Bardet-Biedl syndrome


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Bardet-Biedl syndrome | list9 = AND (pharmacogenomics)}} Genetics of Bardet-Biedl syndromeAND (pharmacogenomics)}} Pharmacogenomics of Bardet-Biedl syndromeAND (proteomics)}} Proteomics of Bardet-Biedl syndrome


| group10 = Newstories on Bardet-Biedl syndrome | list10 = Bardet-Biedl syndrome in the newsBe alerted to news on Bardet-Biedl syndromeNews trends on Bardet-Biedl syndrome</small>


| group11 = Commentary on Bardet-Biedl syndrome | list11 = Blogs on Bardet-Biedl syndrome

| group12 = Patient Resources on Bardet-Biedl syndrome | list12 = Patient resources on Bardet-Biedl syndromeDiscussion groups on Bardet-Biedl syndromePatient Handouts on Bardet-Biedl syndromeDirections to Hospitals Treating Bardet-Biedl syndromeRisk calculators and risk factors for Bardet-Biedl syndrome


| group13 = Healthcare Provider Resources on Bardet-Biedl syndrome | list13 = Symptoms of Bardet-Biedl syndromeCauses & Risk Factors for Bardet-Biedl syndromeDiagnostic studies for Bardet-Biedl syndromeTreatment of Bardet-Biedl syndrome

| group14 = Continuing Medical Education (CME) Programs on Bardet-Biedl syndrome | list14 = CME Programs on Bardet-Biedl syndrome

| group15 = International Resources on Bardet-Biedl syndrome | list15 = Bardet-Biedl syndrome en EspanolBardet-Biedl syndrome en Francais

| group16 = Business Resources on Bardet-Biedl syndrome | list16 = Bardet-Biedl syndrome in the MarketplacePatents on Bardet-Biedl syndrome

| group17 = Informatics Resources on Bardet-Biedl syndrome | list17 = List of terms related to Bardet-Biedl syndrome


}}da:Moon-Bardet-Biedl syndrom de:Laurence-Moon-Biedl-Bardet-Syndromnl:Syndroom van Laurence-Moon-Bardet-Biedl fi:Bardet-Biedlin oireyhtymä



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages